Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. J of Skin. 2018;2(S1):S3. doi:10.25251/skin.2.supp.3